Armour Alison A. 4
4 · ENDOCYTE INC · Filed Dec 19, 2018
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Armour Alison A.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2018-12-17$3.18/sh+14,212$45,194→ 150,252 total - Exercise/Conversion
Stock option (right to buy)
2018-12-17−1→ 39,999 totalExercise: $2.16Exp: 2027-02-02→ Common Stock (1 underlying) - Exercise/Conversion
Stock option (right to buy)
2018-12-17−35,000→ 25,000 totalExercise: $5.16Exp: 2025-07-31→ Common Stock (35,000 underlying) - Exercise/Conversion
Common Stock
2018-12-17$5.16/sh+35,000$180,600→ 136,040 total - Exercise/Conversion
Common Stock
2018-12-17$2.16/sh+1$2→ 150,253 total - Exercise/Conversion
Stock option (right to buy)
2018-12-17−14,212→ 45,788 totalExercise: $3.18Exp: 2026-02-04→ Common Stock (14,212 underlying)
Footnotes (3)
- [F1]Shares subject to this option vest 1/4 annually over a period of four years beginning July 31, 2016.
- [F2]Shares subject to this option vest 1/4 annually over a period of four years beginning February 4, 2017.
- [F3]Shares subject to this option vest 1/4 annually over a period of four years beginning February 2, 2018.